Immuneering (IMRX) Total Assets (Quarterly): 202.06M

Immuneering Corp. (IMRX)

4.07 +0.04 (+0.99%) USD | NASDAQ | Oct 02, 16:00

4.07 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2020. Start Trial.

Date	Value
June 30, 2026	202.06M
March 31, 2026	214.81M
December 31, 2025	231.98M
September 30, 2025	241.06M
June 30, 2025	40.06M
March 31, 2025	50.68M
December 31, 2024	52.71M
September 30, 2024	68.56M
June 30, 2024	77.09M
March 31, 2024	87.98M
December 31, 2023	102.58M
September 30, 2023	113.88M

Date	Value
June 30, 2023	124.90M
March 31, 2023	107.70M
December 31, 2022	122.37M
September 30, 2022	133.69M
June 30, 2022	142.05M
March 31, 2022	152.45M
December 31, 2021	166.70M
September 30, 2021	164.04M
June 30, 2021	53.04M
March 31, 2021	32.86M
December 31, 2020	38.47M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks